Applications of 1-[2-(Morpholin-4-Yl)-Ethyl]-Piperazine in Industrial Manufacturing

1-[2-(Morpholin-4-Yl)-Ethyl]-Piperazine demonstrates targeted performance in several strictly regulated chemical manufacturing sectors. As a direct manufacturer, we have optimized our raw material for high-consistency supply chains, advanced process integration, and regulatory-driven production requirements. Below, we outline key downstream application scenarios based on commercial-scale usage, formulation specifics, and documented compliance obligations.

1. Active Pharmaceutical Ingredient (API) Intermediate for CNS Drug Synthesis

This compound is primarily used as a core intermediate in the multi-step synthesis of select central nervous system (CNS) active drugs. Customers incorporate it in both batch and continuous reactor systems, typically following ICH Q7 GMP requirements. It participates in N-alkylation reactions forming piperazine-containing drug scaffolds. Strict control over impurity profile and traceability is maintained throughout all intermediate handling steps. Qualifying the material requires validated analytical methods and secure supply documentation.

Industry compliance standards

• ICH Q7 GMP for APIs
• European Pharmacopoeia Monographs (relevant to final API)
• US FDA 21 CFR Part 211 for CGMP Finished Pharmaceuticals
• OECD Good Laboratory Practice (applies during pre-clinical stage)

Typical usage ratio

• 0.15–0.35 molar equivalents, adjusted against primary amine reactant and specific route yield
• Excess up to 1.2X in continuous flow processes to drive complete conversion

Downstream process integration

• Charged in secondary amination or N-alkylation step following aromatic halide activation
• Introduced with controlled addition using automated dosing pumps for impurity control
• Intermediate isolation by crystallization or liquid-liquid extraction before final API coupling

Final product types

• Generic CNS actives (antipsychotics, antidepressants, anxiolytics containing piperazine ring)
• Proprietary neuropsychiatric drug candidates (early and late-stage pipeline assets)
• Regulated API intermediates sold to EU and US market authorization holders

2. Corrosion Inhibitor Component in Water Treatment Chemicals

As a building block for water treatment formulations, this material reacts with fatty acids and alkyl halides to yield substituted piperazine derivatives serving as corrosion inhibitors. Industrial blenders incorporate this compound into synthesis stages at strictly defined ratios, balancing cost and efficacy. Process audits and finished batch QC routines ensure compliance with global environmental and health regulations, especially relating to toxicity and degradability.

Industry compliance standards

• US EPA 40 CFR 141.32 (Drinking Water Additives)
• REACH Annex XVII for environmental and workplace safety
• NSF/ANSI 60 for Drinking Water Treatment Chemicals
• ISO 9001:2015 Quality Management System

Typical usage ratio

• 5–12% by weight in final corrosion inhibitor concentrate
• Ratio tuned based on water system pH, target metal, and environmental exposure limit

Downstream process integration

• Charged to reactor during condensation or amide formation with fatty acids
• pH controlled mixing ensures compatibility with other organic and inorganic inhibitors
• Batch samples assayed for total nitrogen, byproduct formation, and % active ingredient prior to packaging

Final product types

• Industrial closed-loop cooling system additives
• Pipeline and boiler corrosion inhibitor solutions
• Formulated water treatment chemicals for export markets

3. Modifying Agent in Polyurethane (PU) and Epoxy Resins

The piperazine derivative serves as a chain extender and crosslinker in specialty PU and epoxy resin synthesis. Compounders deploy it to adjust the flexibility, hydrophilicity, and chemical resistance of foams, coatings, and adhesives. The compound’s compatibility with isocyanate and epoxy systems enables tuning of cure speeds and end-use thermal/chemical properties. Quality and safety documentation centers on occupational exposure limits, toxicity, and product traceability.

Industry compliance standards

• EU REACH registration as industrial chemical intermediate
• ISO 14001 Environmental Management (production site requirement)
• ASTM D2578 for Wetting and Surface Tension of Polymeric Films
• OSHA 29 CFR 1910.1200 for worker safety data sheet compliance

Typical usage ratio

• 0.5–3% by weight in polyurethane prepolymer formulations
• Up to 5% in specialty epoxy blends, determined by targeted modulus and flexibility

Downstream process integration

• Fed to resin blend tank with continuous stirring at controlled temperature
• Added during pre-polymerization to control molecular weight distribution and crosslink density
• Integrated QC verifies purity and amine value prior to addition

Final product types

• PU insulation foams for construction and refrigeration
• High-performance epoxy adhesives (for automotive, electronic, and marine)
• Coatings for industrial floors and chemical storage

4. Intermediate for Synthesis of Piperazine-Based Performance Surfactants

Manufacturers of specialized surfactants use this material as a nucleophilic intermediate for producing piperazine-based surface-active agents. The process typically includes alkylation and oxidation steps, followed by neutralization. Batch release requires conformity with regional chemical inventories and downstream application directives, especially where the surfactant enters regulated personal care or agrochemical applications. QC protocols ensure narrow range of unreacted amine and consistent color.

Industry compliance standards

• EU REACH (Annex V) and listed on EINECS/ELINCS
• US TSCA inventory compliance
• OECD Guidelines for Chemical Safety Testing
• ISO 22716 GMP for cosmetic raw material supply (where relevant)

Typical usage ratio

• 0.7–1.1 molar equivalents versus alkylating agent in surfactant synthesis
• Adjusted based on desired HLB (hydrophilic-lipophilic balance) of final surfactant

Downstream process integration

• Introduced in primary reactor under controlled temperature for nucleophilic substitution
• Followed by in situ neutralization and phase separation
• Monitoring: spectrophotometric tracking of amine conversion and surfactant purity

Final product types

• Amphoteric surfactants for agrochemical formulations
• Specialty emulsifiers for industrial cleaning products
• Performance wetting agents for textile finishing

5. Precursor for Custom Antimicrobial Agents in Industrial Biocides

Formulators employ this raw material to synthesize quaternized piperazine derivatives, valued for their broad-spectrum antimicrobial activity. Synthesis requires stringent control over reaction stoichiometry and complete quaternization. Regulatory focus surrounds biocidal active registration and full safety profiling, with batch traceability and impurity control at each stage. End-use relevance hinges on meeting importation and workplace regulations for the intended geographic market.

Industry compliance standards

• EU BPR (Regulation (EU) No 528/2012) for Biocidal Products
• US EPA FIFRA for antimicrobial pesticides
• Chinese Ministry of Ecology and Environment biocide registration
• ISO 17025 accreditation for analytical testing laboratories

Typical usage ratio

• 0.9–1.2 molar equivalents relative to alkylating or quaternizing agent
• Adjustment based on required minimum inhibitory concentration (MIC) in end-use application

Downstream process integration

• Loaded during the alkylation step of quaternary ammonium salt manufacturing
• Yield and conversion rate monitored by HPLC or NMR throughout batch or flow process
• Followed by filtration/purification for desired purity and product stability

Final product types

• Industrial surface disinfectants (non-residential sectors)
• Cooling tower and oilfield biocides
• Preservatives for paints and polymer dispersions